Search research articles
Contact Us
Filters
Showing results (291-300 of 428) with videos related to
Page
of 43
Sort By:
Investigative Ophthalmology & Visual Science
|
April 16, 2016
Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye
Nizar Saleh Abdelfattah, Hongyang Zhang, David S Boyer, et al.
Transplantation Proceedings
|
November 20, 1997
Plasma amino acid study during discordant liver xenoperfusion
M Adham, C Vianey-Saban, C Ducerf, et al.
Frontiers in Cellular Neuroscience
|
September 10, 2025
Retinal progenitor cells (jCell) for retinitis pigmentosa
Jing Yang, Baruch D Kuppermann, David Liao, et al.
The American Review of Respiratory Disease
|
June 1, 1974
Hypersensitivity lung disease in the turkey raising industry
R S Boyer, L E Klock, C D Schmidt, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
October 14, 2022
The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b Study
David S Boyer, Peter K Kaiser, George N Magrath, et al.
American Journal of Infection Control
|
July 16, 2015
Prolonged delay for controlling KPC-2-producing Klebsiella pneumoniae outbreak: the role of clinical management
T Delory, E Seringe, G Antoniotti, et al.
Ophthalmology
|
February 3, 2016
Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program
Diana V Do, Quan Dong Nguyen, Robert Vitti, et al.
Ophthalmology. Retina
|
May 7, 2026
Effects of Time From Diagnosis to Treatment and Baseline Vision on Retinal Vein Occlusion Outcomes in Aflibercept 2 mg Phase 3 Trials
Sumit Sharma, Dilsher S Dhoot, Dilraj S Grewal, et al.
Journal of Vitreoretinal Diseases
|
August 16, 2024
Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema
Christine Morozova, Lucas L Humayun, Jonathan Kasper, et al.
The New England Journal of Medicine
|
October 6, 2006
Ranibizumab for neovascular age-related macular degeneration
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, et al.
Page
of 43
Search research articles
Search
Showing results (291-300 of 428) with videos related to
Sort By:
Page
of 43
Investigative Ophthalmology & Visual Science
|
April 16, 2016
Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye
Nizar Saleh Abdelfattah, Hongyang Zhang, David S Boyer, et al.
Transplantation Proceedings
|
November 20, 1997
Plasma amino acid study during discordant liver xenoperfusion
M Adham, C Vianey-Saban, C Ducerf, et al.
Frontiers in Cellular Neuroscience
|
September 10, 2025
Retinal progenitor cells (jCell) for retinitis pigmentosa
Jing Yang, Baruch D Kuppermann, David Liao, et al.
The American Review of Respiratory Disease
|
June 1, 1974
Hypersensitivity lung disease in the turkey raising industry
R S Boyer, L E Klock, C D Schmidt, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
October 14, 2022
The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b Study
David S Boyer, Peter K Kaiser, George N Magrath, et al.
American Journal of Infection Control
|
July 16, 2015
Prolonged delay for controlling KPC-2-producing Klebsiella pneumoniae outbreak: the role of clinical management
T Delory, E Seringe, G Antoniotti, et al.
Ophthalmology
|
February 3, 2016
Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program
Diana V Do, Quan Dong Nguyen, Robert Vitti, et al.
Ophthalmology. Retina
|
May 7, 2026
Effects of Time From Diagnosis to Treatment and Baseline Vision on Retinal Vein Occlusion Outcomes in Aflibercept 2 mg Phase 3 Trials
Sumit Sharma, Dilsher S Dhoot, Dilraj S Grewal, et al.
Journal of Vitreoretinal Diseases
|
August 16, 2024
Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema
Christine Morozova, Lucas L Humayun, Jonathan Kasper, et al.
The New England Journal of Medicine
|
October 6, 2006
Ranibizumab for neovascular age-related macular degeneration
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, et al.
Page
of 43